The number of women who told Rose they had filed for divorce, cut off a sibling, or resigned from a job they'd loved — and later wondered whether perimenopause had been a silent co-author of that decision — was not small. That doesn't mean the decisions were wrong. It means they deserved more information than they were given at the time. This article exists because that information gap is not acceptable.
Learn more about Rose →Estrogen has a well-documented modulatory effect on the amygdala — the brain region responsible for detecting threat and generating fear and anger responses. As estrogen levels fluctuate and decline during perimenopause, the amygdala becomes measurably more reactive, responding to interpersonal stress with greater intensity and for longer durations than it would in a hormonally stable state. This means that a partner's comment, a recurring argument, or a pattern of feeling unseen can land with a neurological force that is physiologically amplified beyond its objective weight.
Progesterone metabolizes into allopregnanolone, a neurosteroid that acts on GABA-A receptors — the same receptors targeted by anti-anxiety medications — producing feelings of calm, emotional steadiness, and resilience. In perimenopause, progesterone levels become erratic and then decline, which means this endogenous anxiolytic effect becomes unreliable and eventually disappears. Women may experience a baseline anxiety, irritability, or sense of impending doom that has a direct biochemical cause, and which can make relationships feel unsustainable when they might previously have felt merely imperfect.
The prefrontal cortex governs impulse control, consequence assessment, empathy, and long-term planning — precisely the cognitive tools needed for sound relationship decisions. Even moderate sleep deprivation, defined in research as fewer than six hours per night, measurably reduces prefrontal cortex activity while simultaneously increasing amygdala reactivity, producing a neurological state that researchers describe as functionally similar to being emotionally dysregulated. Night sweats and sleep disruption affect up to 85% of perimenopausal women, meaning many are making high-stakes decisions while operating with the emotional regulation capacity of someone running on fumes.
Estrogen upregulates serotonin receptors and increases dopamine synthesis and release, which means falling estrogen levels directly reduce the neurochemical substrates of mood stability, motivation, and reward sensitivity. When the reward signaling associated with a relationship — connection, affection, shared pleasure — is neurochemically dampened, a partnership can feel genuinely unrewarding in a way that is difficult to distinguish from a truthful relational assessment. Research consistently shows that perimenopausal women have elevated rates of major depressive disorder, and depression itself is a well-documented distorter of relationship satisfaction and perceived partner quality.
Many women in perimenopause report difficulty retrieving complex or emotionally layered memories — not amnesia, but a kind of flattening of accessible context. When evaluating a long-term relationship, the brain normally draws on a rich archive of positive and neutral experiences to balance present frustration; when that retrieval is impaired, the emotional ledger can tip disproportionately toward recent negative experiences. This is not a flaw in perception so much as a temporary change in the cognitive infrastructure that underlies fair retrospective judgment.
Genitourinary syndrome of menopause (GSM) causes vaginal atrophy, dryness, and discomfort with penetrative sex, and declining estrogen also lowers the threshold for skin sensitivity and physical discomfort more broadly. When physical intimacy becomes painful or unpleasant and the underlying cause is not identified or treated, women can reasonably but incorrectly conclude that attraction or love has simply ended, when the actual cause is a treatable physiological change in tissue and nerve sensitivity. This conflation of physical symptom with relational feeling is one of the most consequential and least-discussed drivers of relationship rupture in midlife.
Perimenopause coincides with a well-documented psychological individuation process — sometimes called the midlife transition — in which women reassess identity, purpose, and relational roles with unusual urgency. This psychological layer interacts with the neurobiological disruption to create a state where everything feels simultaneously clearer and more intolerable, a combination that can generate the subjective conviction that radical change is not only warranted but overdue. Research in developmental psychology suggests this individuation phase is real and important, but its timing inside peak hormonal volatility means the signal is being transmitted through a distorted neural medium.
The hypothalamic-pituitary-adrenal (HPA) axis, which governs cortisol release, becomes dysregulated during perimenopause, partly because estrogen helps modulate cortisol response. Women in perimenopause often show flattened cortisol curves, elevated baseline cortisol, and exaggerated cortisol responses to moderate stressors — a physiological profile associated with burnout, hypervigilance, and a lowered tolerance for ambiguity or relational friction. Living in a state of chronic low-grade physiological stress makes environments and relationships that were previously manageable feel genuinely threatening or unbearable.
When women do not have a framework for understanding why they feel so different — so irritable, so disconnected, so done — they tend to search for an external cause, and the most available candidate is usually the relationship or the person in it. This attribution error, where an internal neurobiological state is interpreted as evidence of an external problem, is not a failure of intelligence but a predictable cognitive response to unexplained suffering. Research on medical gaslighting and delayed perimenopause diagnosis suggests that many women reach a decision point having never been told that their neurological and emotional experience has a documented physiological explanation — and that it may be temporary or treatable.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.